We assumed that NCK1-AS1 could affect glioma progression through the miR-138-2-3p/TRIM24 network and the following Wnt/β-catenin pathway, with gain- and loss-of functions of these molecules performed in both cell and animal experiments to validate this hypothesis. This evidence concerns the gene NCK1 and central nervous system cancer.